Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

Subjects:

Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

Subjects:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

Subjects:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Subjects:

Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

Subjects:

Study Flow Diagram. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Subjects:

Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

Subjects:

Temperature-Responsive Peptide–Nucleotide Coacervates by Tiemei Lu (4244926)

“…We derive a simple relation between the temperature and salt concentration at the critical point based on a mean-field model of phase separation. …”

Temperature-Responsive Peptide–Nucleotide Coacervates by Tiemei Lu (4244926)

“…We derive a simple relation between the temperature and salt concentration at the critical point based on a mean-field model of phase separation. …”

Table_1_S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic Leukemia Cells.DOCX by Ji-Sook Lee (632672)

“…The surface TLR4 expression increased after exposure to S100A8 and S100A9 although total TLR4 expression decreased. …”

Table_2_S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic Leukemia Cells.DOCX by Ji-Sook Lee (632672)

“…The surface TLR4 expression increased after exposure to S100A8 and S100A9 although total TLR4 expression decreased. …”

Presentation_1_S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic Leukemia Cells.PPT by Ji-Sook Lee (632672)

“…The surface TLR4 expression increased after exposure to S100A8 and S100A9 although total TLR4 expression decreased. …”

Mean score and proportion of selected items among women gave birth in Hossana town administration, southern Ethiopia, 2018. by Getachew Ossabo Babore (10788843)

List of selected metabolites that associate with diabetes at q-values <0.05 using log-scaled metabolite concentrations and assuming a linear model; %change is the increase or decre... by Karsten Suhre (67967)

Transient kinetic analysis of the S100A4-N-ERMAD interaction. by Beáta Biri-Kovács (4020650)

“…<p>(A, B) 2 μM N-ERMAD or F2 lobe (respectively) was mixed with an equal volume of S100A4 in different concentrations and a decrease in intrinsic Trp fluorescence was monitored over time (left panel). …”